These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 31619722
1. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study. Fujita Y, Doi Y, Hamano T, Hatazaki M, Umayahara Y, Isaka Y, Tsubakihara Y. Sci Rep; 2019 Oct 16; 9(1):14871. PubMed ID: 31619722 [Abstract] [Full Text] [Related]
3. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology. Gowanlock Z, Sriram S, Martin A, Xenocostas A, Lazo-Langner A. PLoS One; 2016 Oct 16; 11(6):e0157279. PubMed ID: 27310832 [Abstract] [Full Text] [Related]
4. Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease. Kim IY, Kim JH, Kim MJ, Lee DW, Hwang CG, Han M, Rhee H, Song SH, Seong EY, Lee SB. Int Urol Nephrol; 2018 Dec 16; 50(12):2255-2260. PubMed ID: 30136086 [Abstract] [Full Text] [Related]
5. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study. Yamanouchi M, Furuichi K, Hoshino J, Toyama T, Hara A, Shimizu M, Kinowaki K, Fujii T, Ohashi K, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Mise K, Makino H, Matsuo S, Ubara Y, Wada T, Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development. Diabetes Care; 2019 May 16; 42(5):891-902. PubMed ID: 30833372 [Abstract] [Full Text] [Related]
7. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease. Wagner M, Alam A, Zimmermann J, Rauh K, Koljaja-Batzner A, Raff U, Wanner C, Schramm L. Clin J Am Soc Nephrol; 2011 Jul 16; 6(7):1573-9. PubMed ID: 21734083 [Abstract] [Full Text] [Related]
9. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study. Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE. Am J Kidney Dis; 2018 Nov 16; 72(5):653-661. PubMed ID: 29784612 [Abstract] [Full Text] [Related]
10. The influence of sex on renal function decline in people with Type 2 diabetes. de Hauteclocque A, Ragot S, Slaoui Y, Gand E, Miot A, Sosner P, Halimi JM, Zaoui P, Rigalleau V, Roussel R, Saulnier PJ, Hadjadj Samy S, SURDIAGENE Study group. Diabet Med; 2014 Sep 16; 31(9):1121-8. PubMed ID: 24773061 [Abstract] [Full Text] [Related]
13. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A, Japan Diabetes Clinical Data Management Study Group. Diabetologia; 2012 Jul 16; 55(7):1911-8. PubMed ID: 22476921 [Abstract] [Full Text] [Related]
14. Annual deterioration of renal function in hypertensive patients with and without diabetes. Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S. Vasc Health Risk Manag; 2017 Jul 16; 13():231-237. PubMed ID: 28721063 [Abstract] [Full Text] [Related]
15. Anemia with impaired erythropoietin response in diabetic patients. Thomas MC, Cooper ME, Tsalamandris C, MacIsaac R, Jerums G. Arch Intern Med; 2005 Feb 28; 165(4):466-9. PubMed ID: 15738380 [Abstract] [Full Text] [Related]
16. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters. Florit EA, Hadad F, Rodriguez Cubillo B, De la Flor JC, Valga F, Perez Flores I, Calvo Romero N, Valero San Cecilio R, Barrientos Guzman A, Sanchez Fructuoso A. Transplant Proc; 2012 Nov 28; 44(9):2590-2. PubMed ID: 23146464 [Abstract] [Full Text] [Related]
17. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes. Pena MJ, Heinzel A, Heinze G, Alkhalaf A, Bakker SJ, Nguyen TQ, Goldschmeding R, Bilo HJ, Perco P, Mayer B, de Zeeuw D, Lambers Heerspink HJ. PLoS One; 2015 Nov 28; 10(5):e0120995. PubMed ID: 25973922 [Abstract] [Full Text] [Related]